Fludeoxyglucose F-18 Injection, Solution
Product Images NDC 52768-001

Fludeoxyglucose F 18 Injection is a diagnostic radiopharmaceutical intended for intravenous use and contains 0.74 GBq - 18.5 GBq (20 mCi - 500 mCi), of no carrier added 2-deoxy-2-['8F]-fluoro-D-glucose. It's manufactured by Precision Nuclear LLC and comes in a multiple-dose vial. The drug should be stored upright in a shielded container between 20°C-25°C (68°F-77°F), with permitted excursions to 15-30°C (59-86°F) and is stabilized with 0.05 to 0.5 % w/w ethanol. One should withdraw and handle doses aseptically and not use it if the solution is cloudy or contains particulate matter. The drug should be used with caution, and the correct dosage should be calculated from date and time of calibration (EOS = End of Synthesis).*

Fludeoxyglucose F 18 injection is a radiopharmaceutical used for diagnostic purposes through intravenous use. It comes in a sterile, non-pyrogenic multiple-dose vial containing 0.74 GBq - 18.5 GBq (20 mCi - 500 mCi) of no carrier added 2-deoxy-2-['8F]-fluoro-D-glucose. The injection must be used within 12 hours after the end of synthesis, and the correct dosage must be calculated based on the date and time of calibration. It should be stored upright in a shielded container at 20° to 25°C (68° to 77°F) with possible excursions permitted to 15-30°C (59-86°F). The injection is stabilized with 0.05 to 0.5% w/w ethanol and must not be used if cloudy or contains particulate matter.*

This is a cautionary label for Fludeoxyglucose F 18 Injection, which is a diagnostic radioactive material used intravenously. The injection is sterile, non-pyrogenic and ranges from 20 mCi/mL to 500 mCi/mL. It is manufactured by "recision Nuclear, LLC". Each mL contains 0.74 GBq - 18.5 GB (20 mGi - 500 mCi), of no carrier added 2-deoxy-2-{**Flfluoro-D-glucose. The injection should be stored upright in a shielded container at 20° to 25°C (68° to 77 °F), excursions permitted to 15-30°C (59-86°F). The radioactive material should be stabilized with 0.05 to 0.5 % w/w ethanol, and doses should be withdrawn and handled aseptically. If it is cloudy or contains particulate matter, do not use it. The label also instructs the calculation of the correct dosage from the date and time of calibration.*

Fludeoxyglucose F 18 Injection is a radioactive diagnostic used for intravenous use only. Each mL contains 0.74 GBq - 18.5 GBq (20 mGi - 500 mCi), of no carrier added 2-deoxy-2-[**Flfluoro-D-glucose at EOS*, and 4.5 mg of sodium chloride in citrate buffer. It is stabilized with 0.05 to 0.5% w/w ethanol and should be aseptically withdrawn and handled. It has a half-life of 109.7 minutes and should be stored upright in a shielded container at 20° to 25°C (68° to 77°F), with excursions permitted to 15-30°C (59-86°F). The correct dosage should be calculated from the date and time of calibration. Lot number, calibration, expiration date, radioactivity, and manufacturer information are provided. Caution: Rx Only Sterile, Non-pyrogenic.*